7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18268746 | STABLE ANTIBODY FORMULATION, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF | GURLEY, JAMI MICHELLE | 1647 | Non-Final OA | Jun 21, 2023 |
| 18037401 | USE OF ANTI-OX40 ANTIBODY IN TREATMENT OF TUMOR OR CANCER | CHHAY, BONIRATH | 1645 | Non-Final OA | May 17, 2023 |
| 18035591 | BISPECIFIC ANTIBODY AND USE THEREOF | STOICA, ELLY GERALD | 1647 | Non-Final OA | May 05, 2023 |
| 18021698 | LIQUID FORMULATIONS COMPRISING HIGH CONCENTRATIONS HUMANIZED ANTIBODIES FOR TREATING IL-6 RELATED DISEASES | REDDIG, PETER J | 1646 | Final Rejection | Feb 16, 2023 |
| 18007262 | ANTI-HER2 ANTIBODY AND USE THEREOF | OGUNBIYI, OLUWATOSIN A | 1645 | Non-Final OA | Jan 27, 2023 |
| 17800791 | ANTI-TNF-a ANTIBODY FORMULATION, PREPARATION METHOD THEREFOR AND USE THEREOF | KIM, YUNSOO | 1641 | Final Rejection | Aug 18, 2022 |
| 17767990 | ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY FOR TREATMENT OF CD20 POSITIVE DISEASES | KIM, YUNSOO | 1641 | Non-Final OA | Apr 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial